MedTrace Logo

Evaluation of Culture Negative Severe Acute Respiratory Infection in Mexico

NCT03168282 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2018-11-06

No results posted yet for this study

Summary

The purpose of this study is to determine the feasibility of identifying novel etiologic agents associated with SARI in patients who have required intubation and in whom, after analysis, a causative agent was not identified by standard microbiologic (culture) and multiplex real-time Polymerase Chain Reaction (PCR) platforms. Taking into account that isolation of any pathogens is generally time sensitive, the study will evaluate subjects that are culture negative at the time of consent. Not all subjects will actually prove to be culture negative. Additionally, the study will compare etiologic agents identified on broncho-alveolar lavage (BAL) to etiologic agents identified by routine upper airway testing on all subjects with SARI.

Conditions

  • Severe Acute Respiratory Infection (SARI)

Sponsors & Collaborators

  • Secretaria de Salud, Mexico

    collaborator OTHER_GOV

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Mexican Emerging Infectious Diseases Clinical Research Network

    lead NETWORK

Principal Investigators

  • Arturo Galindo-Fraga · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

  • Santiago Pérez Patrigeon · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-06
Primary Completion
2018-04-11
Completion
2018-04-11

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03168282 on ClinicalTrials.gov